Novo Nordisk joined the many pharmaceutical companies pushing back on government-negotiated drug pricing in the United States.

The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers over insulin pricing practices will likely move ...

As the obesity rate among people with type 1 diabetes rises, patients are taking popular weight loss drugs like Ozempic—and ...

The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes ...

Discover which herbs can naturally help regulate blood sugar levels. Learn which herbs work like insulin and how to safely ...

Analysts said tariffs would send prescription drug prices higher. Generic drugs and ingredients that are largely made ...

Missed and delayed medication putting A&E patients at risk, new report reveals - 68 per cent of prescription doses were not ...

A controversial lawsuit brought by the FTC against the largest PBMs over insulin pricing was delayed in part by Trump firings ...

April 2 (Reuters) - The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth (UNH.N), opens new tab, Cigna (CI.N), opens new tab and CVS ...

Five researchers have been jointly awarded one of this year's Breakthrough Prizes in Life Sciences for their contributions to ...

The agency has paused its lawsuit against three pharmacy-benefit managers because no current commissioners can participate in ...